Gregory Francis William Gocal Sells 2,000 Shares of Cibus, Inc. (NASDAQ:CBUS) Stock

Cibus, Inc. (NASDAQ:CBUS) EVP Gregory Francis William Gocal sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, July 12th. The shares were sold at an average price of $10.00, for a total transaction of $20,000.00. Following the completion of the transaction, the executive vice president now owns 316,844 shares of the company’s stock, valued at $3,168,440. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Gregory Francis William Gocal also recently made the following trade(s):

• On Thursday, June 27th, Gregory Francis William Gocal sold 2,000 shares of Cibus stock. The stock was sold at an average price of $10.00, for a total transaction of $20,000.00.

Cibus Price Performance

CBUS stock traded up $0.43 during trading on Monday, reaching $10.37. 127,204 shares of the company were exchanged, compared to its average volume of 106,308. The company has a 50-day moving average of $12.50 and a two-hundred day moving average of $16.21. The company has a market capitalization of $223.47 million, a price-to-earnings ratio of -0.57 and a beta of 1.91. Cibus, Inc. has a twelve month low of $7.41 and a twelve month high of $24.61.

Cibus (NASDAQ:CBUS) last released its quarterly earnings data on Thursday, May 9th. The company reported ($1.12) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.01) by ($0.11). The company had revenue of $0.55 million for the quarter, compared to analyst estimates of $0.40 million. Cibus had a negative return on equity of 23.33% and a negative net margin of 12,313.28%. During the same quarter in the prior year, the company earned ($5.45) earnings per share. On average, analysts forecast that Cibus, Inc. will post -3.22 EPS for the current year.

Institutional Investors Weigh In On Cibus

A number of institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in Cibus by 3.7% during the 1st quarter. Vanguard Group Inc. now owns 721,945 shares of the company’s stock worth $16,215,000 after acquiring an additional 26,017 shares during the last quarter. Indie Asset Partners LLC boosted its stake in shares of Cibus by 30.1% in the 4th quarter. Indie Asset Partners LLC now owns 16,929 shares of the company’s stock valued at $332,000 after purchasing an additional 3,921 shares during the last quarter. Blue Trust Inc. bought a new stake in shares of Cibus in the 4th quarter valued at $301,000. Cerity Partners LLC bought a new stake in shares of Cibus in the 4th quarter valued at $323,000. Finally, Citigroup Inc. bought a new stake in shares of Cibus in the 3rd quarter valued at $199,000. 33.81% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reiterated a “buy” rating and set a $25.00 price objective on shares of Cibus in a research report on Friday, May 10th.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.